Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
19. April 2021 08:00 ET
|
Accolade, Inc.
SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
25. März 2021 04:29 ET
|
Accolade, Inc.
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026...
Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021
23. März 2021 16:03 ET
|
Accolade, Inc.
SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) today provided preliminary unaudited financial results for the fiscal fourth quarter and year ended February 28, 2021...
Accolade Announces Private Offering of $250 Million Convertible Notes
23. März 2021 16:02 ET
|
Accolade, Inc.
SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate...
Accolade Completes Acquisition of 2nd.MD
04. März 2021 08:00 ET
|
Accolade, Inc.
SEATTLE, March 04, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate and utilize the...
Accolade to Participate in Upcoming Investor Conferences
16. Februar 2021 08:00 ET
|
Accolade, Inc.
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade to Acquire 2nd.MD
14. Januar 2021 16:50 ET
|
Accolade, Inc.
The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates...
Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference
11. Januar 2021 08:00 ET
|
Accolade, Inc.
SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...
Accolade Announces Results for Fiscal Third Quarter 2021
07. Januar 2021 16:05 ET
|
Accolade, Inc.
Fiscal third quarter 2021 revenue of $38.4 million, a 30% increase compared to fiscal third quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer additions across market...
Accolade to Announce Fiscal Third Quarter 2021 Financial Results
23. Dezember 2020 08:00 ET
|
Accolade, Inc.
SEATTLE, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the...